KONE Oyj (KNEBV)
Nasdaq Helsinki · Finland · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 56.46 |
|---|---|
| 52-week range | 46.22 – 64.42 |
| Return, 1 month / 3 months | +9.6% / +13.3% |
| Return, 1 year / 3 years | −1.1% / +58.6% |
| Trend | Uptrend |
| RSI (14) | 70 |
| Volatility (1 year) | 20.9% |
| Worst drawdown (1 year) | -24.8% |
| Average daily value traded | 32.60M EUR |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
KONE Oyj is a Finnish engineering company that makes and maintains elevators, escalators and automatic building doors. It serves building owners, developers, architects and facility managers, supplying equipment for new buildings and modernising and servicing installed systems. The company is based in Finland and operates across many countries, with customers in residential, commercial and public building markets. Its work covers the full life of a building's people-flow equipment, from installation through maintenance and repair.
KONE Oyj trades under the code KNEBV on the Nasdaq Helsinki in Finland, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
KONE Oyj (KNEBV) trades on the Nasdaq Helsinki in Finland. It last closed at EUR 56.46 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 37 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.1% and over the last three months it rose 13.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Helsinki
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.2% | ||
| From 52-week high | -11.8% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 13.3% | ||
| 6-month return | -0.8% | ||
| 12-month return, skipping the last month | -9.8% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 20.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.8% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 32.60M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.5% |
|---|---|
| 1 month | +9.6% |
| 3 months | +13.3% |
| 6 months | −0.8% |
| 1 year | −1.1% |
| 3 years | +58.6% |
| 5 years | +11.2% |
Signals
| 50-day / 200-day average | 52.17 / 53.67 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Mar 2026 | EUR 1.8000 |
| 6 Mar 2025 | EUR 1.8000 |
| 1 Mar 2024 | EUR 1.7500 |
| 1 Mar 2023 | EUR 1.7500 |
| 2 Mar 2022 | EUR 0.3500 |
| 3 Mar 2021 | EUR 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Helsinki; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.